Preferred Label : voxelotor;
MeSH synonym : 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)-3-pyridinyl)methoxy)benzaldehyde;
UNII : 3ZO554A4Q8;
Origin ID : C000628792;
UMLS CUI : C4723629;
ATC code(s)
- Currated CISMeF NLP mapping
- MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3448025/fr/oxbryta-voxelotor-anemie-hemolytique
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
voxelotor
hematologic agents
anemia, sickle cell
adult
adolescent
summary of product characteristics
drug therapy, combination
evaluation of the transparency committee
voxelotor
anemia, hemolytic
---
https://ansm.sante.fr/tableau-acces-derogatoire/oxbryta-voxelotor
2023
false
false
false
France
French
risk management
voxelotor
voxelotor
administration, oral
hematologic agents
drug information
anemia, hemolytic
anemia, sickle cell
---
https://www.has-sante.fr/jcms/p_3348600/fr/oxbryta-voxelotor-carcinome-urothelial-anemie-hemolytique
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
voxelotor
drug therapy, combination
anemia, sickle cell
administration, oral
voxelotor
hydroxyurea
adult
adolescent
evaluation of the transparency committee
voxelotor
---
https://www.ema.europa.eu/en/medicines/human/EPAR/oxbryta
2022
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
voxelotor
voxelotor
voxelotor
orphan drug production
anemia, sickle cell
Oxbryta
drug approval
europe
adolescent
adult
administration, oral
aged
hematologic agents
hematologic agents
product surveillance, postmarketing
pregnancy
breast feeding
drug therapy, combination
drug interactions
hemoglobin, sickle
drug evaluation, preclinical
---
https://www.has-sante.fr/jcms/p_3361556/fr/oxbryta-voxelotor-anemie-hemolytique-severe
2022
false
false
false
France
insurance, health, reimbursement
treatment outcome
voxelotor
administration, oral
hematologic agents
adult
adolescent
drug therapy, combination
hydroxyurea
evaluation of the transparency committee
Oxbryta
voxelotor
anemia, sickle cell
---
https://ansm.sante.fr/tableau-atu-rtu/voxelotor-500-mg-comprimes-pellicules
2021
false
false
false
France
French
voxelotor
anemia, sickle cell
Product containing only voxelotor in oral dose form (medicinal product form)
guidelines for drug use
voxelotor
benzaldehydes
pyrazines
pyrazoles
---
